Vaginoses Bacterianas na Gestação: uma revisão sistemática / Bacterial Vaginosis in Pregnancy: a systematic review

Lavínia Barcellos Araújo, Marina Martins de Oliveira, Bárbara Neto Campos, Fernanda Rodrigues Martins, Bruna Daflon Machado, Alexandre César Della Garza Ronzani, Gabriela Reis Viol, Ludymilla Ribeiro Bordoni de Oliveira, Ana Luísa dos Santos Maciel, Camila Fonseca Silva Junqueira, Victor Rocha Moreira Antunes

Abstract


INTRODUÇÃO: A vaginose bacteriana (VB) é uma modificação da microbiota vaginal.  Embora essa comorbidade seja frequentemente assintomática, está associada a complicações clínicas. MÉTODOS: Foram analisados os mais relevantes estudos publicados originalmente, na língua inglesa, nos últimos 10 anos, tendo como referência as bases de dados PubMed e Cochrane. Objetivando selecionar os estudos com maior relevância clínica e evidência científica, foram contemplados apenas os ensaios clínicos controlados e randomizados (ECCR). O presente estudo utilizou para formulação da frase de pesquisa o Descritores em Ciências da Saúde (DeCS), encontrado as seguintes palavras-chave: Bacterial Vaginosis; Pregnancy. As variações das palavras-chave anteriormente apresentadas foram consultadas mediante o MeSH. Foi usada a sistematização PRISMA para a elaboração desta revisão.  RESULTADOS: Os artigos analisados foram publicados em periódicos internacionais. A VB pode estar ou não associada à prematuridade e seu tratamento convencional apresentou limitações, sendo a rifaximina mais indicada. CONCLUSÃO:  A VB deve ser investigada e tratada adequadamente durante a gestação, devido ao risco. Entretanto, existem estudos que relatam baixa associação entre a VB e prematuridade, enquanto outros relatam a relação dos dois fatores. Dessa forma, mais estudos devem ser realizados a fim de propor um possível Estado da Arte.


Keywords


Vaginose bacteriana, Gestação, Prematuridade.

References


Abramovici A, Lobashevsky E, Cliver SP, et al. Quantitative Polymerase Chain Reaction to Assess Response to Treatment of Bacterial Vaginosis and Risk of Preterm Birth. Am J Perinatol. 2015;32(12):1119-1125.

Anderson B, Zhao Y, Andrews WW, et al. Effect of antibiotic exposure on Nugent score among pregnant women with and without bacterial vaginosis. Obstet Gynecol. 2011;117(4):844-849.

Bellad MB, Hoffman MK, Mallapur AA, et al. Clindamycin to reduce preterm birth in a low resource setting: a randomised placebo-controlled clinical trial. BJOG. 2018;125(12):1601-1609.

Christian P, Labrique AB, Richman MJ, et al. Maternal vitamin A and β-carotene supplementation and risk of bacterial vaginosis: a randomized controlled trial in rural Bangladesh. Am J Clin Nutr. 2011; 94(6):1643-9.

Cruciani F, Brigidi P, Calanni F, et al. Efficacy of rifaximin vaginal tablets in treatment of bacterial vaginosis: a molecular characterization of the vaginal microbiota. Antimicrob Agents Chemother. 2012;56(8):4062-4070.

Desseauve D, Chantrel J, Fruchart A, et al. Prevalence and risk factors of bacterial vaginosis during the first trimester of pregnancy in a large French population-based study. Eur J Obstet Gynecol Reprod Biol. 2012;163(1):30-34.

Figueroa D, Mancuso MS, Szychowski JM, et al. Does midtrimester Nugent score or high vaginal pH predict gestational age at delivery in women at risk for recurrent preterm birth? Am J Obstet Gynecol. 2011; 204(1):46.e1-4.

Harper LM, Parry S, Stamilio DM, et al. The interaction effect of bacterial vaginosis and periodontal disease on the risk of preterm delivery. Am J Perinatol. 2012;(5):347-52.

Hoffman MK, Bellad MB, Charantimath US, et al. A comparison of colorimetric assessment of vaginal pH with nugent score for the detection of bacterial vaginosis. Infectious Diseases in Obstetrics and Gynecology. 2017;2017(3):1-4.

Jefferson KK, Parikh HI, Garcia EM, et al. Relationship between vitamin D status and the vaginal microbiome during pregnancy. J Perinatol. 2019;39(6):824-836.

Krauss-Silva L, Moreira ME, Alves MB, et al. A randomised controlled trial of probiotics for the prevention of spontaneous preterm delivery associated with bacterial vaginosis: preliminary results. Trials. 2011;12:239.

Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration. PLoS Med. 2009; 339.

Mancuso MS, Figueroa D, Szychowski JM, et al. Midtrimester bacterial vaginosis and cervical length in women at risk for preterm birth. Am J Obstet Gynecol.2011;204(4):342.e1-5.

Otsuki K, Nakai A, Matsuda Y, et al. Randomized trial of ultrasound-indicated cerclage in singleton women without lower genital tract inflammation. J Obstet Gynaecol Res. 2016;42(2):148-57.

Pustotina O. Effectiveness of dydrogesterone, 17-OH progesterone and micronized progesterone in prevention of preterm birth in women with a short cervix. J Matern Fetal Neonatal Med. 2018;31(14):1830-1838.

Swadpanich U, Lumbiganon P, Prasertcharoensook W, et al. Antenatal lower genital tract infection screening and treatment programs for preventing preterm delivery. Cochrane Database Syst Rev. 2008;16(2):CD006178.

Schwebke JR, Marrazzo J, Beelen AP, et al. A Phase 3, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study Evaluating the Safety and Efficacy of Metronidazole Vaginal Gel 1.3% in the Treatment of Bacterial Vaginosis. Sex Transm Dis. 2015;42(7):376-381.

Subtil D, Brabant G, Tilloy E, et al. Early clindamycin for bacterial vaginosis in pregnancy (PREMEVA): a multicentre, double-blind, randomised controlled trial. Lancet. 2018;392(10160):2171-2179.

Sungkar A, Purwosunu Y, Aziz MF, et al. Influence of early self-diagnosis and treatment of bacterial vaginosis on preterm birth rate. International Journal of Gynecology & Obstetrics. 2012;117(3):264-7.

Stojanović N, Plećaš D, Plešinac S. Normal vaginal flora, disorders and application of probiotics in pregnancy. Arch Gynecol Obstet. 2012;286(2):325-32.




DOI: https://doi.org/10.34117/bjdv6n10-540

Refbacks

  • There are currently no refbacks.